AbCellera Biologics's total assets for Q2 2026 were $1.31B, an increase of 0.04% from the previous quarter. DE:8QQ total liabilities were $411.56M for the fiscal quarter, a 11.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.